Pac-Link Bio Venture Investment

Pac-Link Management is a venture capital firm based in Taipei, Taiwan, and a subsidiary of the Yulon Group. Established in 1998, the firm specializes in early to late-stage investments across diverse sectors, including life sciences, semiconductors, information technology, and automotive industries. Pac-Link has managed over ten funds with a total capital of approximately $430 million, focusing on companies in both Asia and North America. Its life science portfolio includes investments in biotechnology and medical device companies such as Revance Therapeutics, Broncus Technologies, and Trellis Bioscience. The firm provides strategic advisory and capital to help portfolio companies achieve market leadership and operational growth. Pac-Link often collaborates with institutional partners like the Taiwan National Development Fund to support innovation in the regional biotech ecosystem.